Advanced Innovative Partners Press Releases - EIN Presswire

Published on June 22, 2022 - 22:46 GMT

Advanced Innovative Partners Announces Issuance of U.S. Patent for Tumor Targeted Radionuclide Therapy for Cancer

PALM BEACH, FL, UNITED STATES, June 22, 2022 /⁨EINPresswire.com⁩/ -- Advanced Innovative Partners “AIP”, a clinical stage biotechnology company developing targeted therapies for cancer announced that the U.S. Patent and Trademark Office has issued approval …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 1, 2022 - 21:33 GMT

Advanced Innovative Partners Announces Designation for Rare Pediatric Disease Drug

MIAMI, FLORIDA, UNITED STATES, March 1, 2022 /⁨EINPresswire.com⁩/ -- AIP is pleased to announce that the U.S Food and Drug Administration (FDA) has granted Orphan Drug and Rare Pediatric Disease Designation to a radiopharmaceutical for Positron Emission …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 23, 2022 - 22:00 GMT

Advanced Innovative Partners Receives Orphan Designation for Glioblastoma Multiform

SURFSIDE, FLORIDA, UNITED STATES, February 23, 2022 /⁨EINPresswire.com⁩/ -- Advanced Innovative Partners is proud to announce that the Company received orphan drug designation of its proprietary drug for treatment of Glioblastoma Multiforme. The U.S Food …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on October 27, 2021 - 18:13 GMT

Advanced Innovative Partners Continues the Fight Against Breast Cancer

Advanced Innovative Partners Continues the Fight Against Breast Cancer BOYNTON BEACH, FLORIDA, UNITED STATES, October 27, 2021 /⁨EINPresswire.com⁩/ -- – October is National Breast Cancer Month. Miami-based Advanced Innovative Partners continues its fight …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on June 21, 2021 - 22:37 GMT

Chairman Stanley Satz Presenting for the International Atomic Energy Agency on Radiopharmaceuticals for Cancer

Dr. Satz, invited at the ConsultancyMeeting on the Status of Radiopharmaceuticals and AlphaEmitters, covers treatment of some cancers using radiopharmaceuticals MIAMI, FLORIDA, UNITED STATES OF AMERICA, June 21, 2021 /⁨EINPresswire.com⁩/ -- Advanced …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on May 6, 2021 - 18:30 GMT

Advanced Innovative Partners Receives FDA'S Orphan Drug and RPD Designations for Hepatoblastoma Imaging Biomarker

MIAMI, FLORIDA, UNITED STATES OF AMERICA, May 6, 2021 /⁨EINPresswire.com⁩/ -- Advanced Innovative Partners (AIP) is pleased to announce that the U.S Food and Drug Administration (FDA) has granted Orphan Drug and Rare Pediatric Disease (RPD) Designation for …

Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ...

Published on March 25, 2021 - 21:59 GMT

Orphan Drug and Rare Pediatric Disease Designations for a Radiopharmaceutical to Treat Diffuse Intrinsic Pontine Glioma

Advanced Innovative Partners has been granted Designations by America's FDA in order to treat Diffuse Intrinsic Pontoine Glioma MIAMI, FLORIDA, UNITED STATES OF AMERICA, March 25, 2021 /⁨EINPresswire.com⁩/ -- AIP is pleased to announce that the U.S …

Distribution channels: Chemical Industry, Companies ...

Published on February 26, 2021 - 21:23 GMT

Advanced Innovative Partners Receives Multiple Rare Pediatric Disease and Orphan Designations from the FDA

SURFSIDE, FLORIDA, UNITED STATES, February 26, 2021 /⁨EINPresswire.com⁩/ -- Advanced Innovative Partners (AIP), a privately held life sciences company developing rare disease drugs for cancer, today announced that the U.S. Food and Drug Administration (FDA …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...